Artificial Intelligence in Healthcare Market was valued at USD 14.09 billion in 2022. It is projected to reach USD 187.57 billion by 2030, exhibiting a remarkable compound annual growth rate (CAGR) of 38.2% during the forecast period from 2023 to 2030. Artificial Intelligence (AI) has emerged as a transformative force within the healthcare industry, revolutionizing the way medical...

The global biosimulation market size was valued at USD 3.5 billion in 2024, with North America holding a substantial market share. The market is driven by technological advancements in biosimulation software. It is expected to grow at a CAGR of 16.90% during the forecast period of 2025-2034, with the values likely to attain USD 14.1 billion by 2034. This growth is attributed to the expanding...

According to FutureWise analysis the market for biosimulation is expected to register a CAGR of 16.10% from 2024-2032. Bio-simulation is a specialized area within systems biology that provides insights into complex biological systems, both in health and disease. Often referred to as in-silico biology, it involves conducting biological experiments through computer simulations. This innovative...